Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
83 /100
CRITICAL RISK
Score updated Aug 28, 2026

BDMD — Baird Medical Investment Holdings Limited Dilution Risk Tracker

Track BDMD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BDMD — Get alerts when the score changes →

As of August 28, 2026, Baird Medical Investment Holdings Limited (BDMD) has a DilutionWatch DilutionScore of 83/100, rated CRITICAL dilution risk. Baird Medical Investment Holdings Limited has a market capitalization of $47.65M, 40.98M shares outstanding, 9 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
62
💰 Cash Runway
95
📊 Float Risk
77
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 44%
💰 Capital Raise model 55%
• Critical: only 1.6 months cash remaining
🔄 Reverse Split model est. 45%
• 50-day avg $1.78 approaching $1 threshold
• Only 2 months cash — financial pressure
📉 Score Deterioration model 15%
• Score already CRITICAL (83/100) — events likely imminent
🔔 Track BDMD — Get forecast alerts →

Market Data

Market Cap$47.65M
Shares Outstanding40.98M
Float4.66M
Cash$178.3K
Debt$8.72M
Short InterestN/A

Institutional Holdings

9 institutional holders · 602.7K shares
#1 Periscope Capital Inc. 125.0K shares
#2 Highbridge Capital Management, LLC. 125.0K shares
#3 Citadel Advisors Llc 112.7K shares
+ 6 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest20.1K
Days to Cover1.0
% of Float0.4%
FINRA data as of Jul 31, 2026

Recent SEC Activity

EFFECT EFFECT 2026-08-17
EFFECT EFFECT 2026-08-17
3 FORM3 2026-04-21
3 FORM3 2026-04-21
3 FORM3 2026-04-21
Full SEC filing analysis available with free account

Recent News

Factual BDMD Dilution Snapshot

Baird Medical Investment Holdings Limited (BDMD) has a DilutionScore of 83/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track BDMD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BDMD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BDMD
BDMD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.